A Study to Evaluate EDP 938 Regimens in Children With RSV
Study sponsor: Enanta Pharmaceuticals, Inc · ENTA
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2024-08-19Actual
Enrollment · participants99Actual
Source updated2025-07-28Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.